bit.bio + Pint of Science

SubscribeSpotify | TuneIn | Stitcher | Apple

We have a special three part mini-series of podcasts in collaboration with bit.bio, the cell-coding company. 

Episode 1: CEO and founder Dr Mark Kotter

The series kicks off with Dr Mark Kotter, founder and CEO of bit.bio, the cell coding company. He covers the concept of regenerative medicine and in particular how we might use this approach for neurological conditions and spinal cord injuries – he has a personal interest as he’s a neurosurgeon as well as a CEO and founder. He reveals how bit.bio is working to harness the power of stem cells and turn them into medicines by looking at biology in a different way – like a software.

Headshot of Dr Mark Kotter

Dr Mark Kotter

Mark said: “We were able to create a control system that allows us to jumpstart the programs of the cell very effectively. We call this opti-ox™ - it takes full control of the cells identity and has made the process of cell reprogramming very robust and therefore scalable.

You can find Mark on Twitter @MarkKotter 

Interested in precise reprogramming of cells? See the video of bit.bio’s opti-ox™ technology reprogramming stem cells into functional skeletal muscle.